A Melbourne-based startup that uses artificial intelligence to enable home glaucoma testing on laptop or tablet screens has finalised its oversubscribed $2.6 million seed round raise.
Eyeonic aims to transform glaucoma screening through cutting-edge technology. Its AI-enabled online visual glaucoma testing delivers diagnostic capability on any computer or tablet, eliminating the need for specialised machines and personnel.
Glaucoma is a leading cause of irreversible blindness globally, and early detection is vital to prevent vision loss. Eyeonic’s technology ensures that more patients can be screened accurately and conveniently, advancing medical diagnostics and improving patient outcomes.
Founded by associate professor Simon Skalicky, Eyenonic’s tech enhances accessibility and affordability, particularly benefiting underserved regions where traditional diagnostic tools are scarce.
COMMENTS
SmartCompany is committed to hosting lively discussions. Help us keep the conversation useful, interesting and welcoming. We aim to publish comments quickly in the interest of promoting robust conversation, but we’re a small team and we deploy filters to protect against legal risk. Occasionally your comment may be held up while it is being reviewed, but we’re working as fast as we can to keep the conversation rolling.
The SmartCompany comment section is members-only content. Please subscribe to leave a comment.
The SmartCompany comment section is members-only content. Please login to leave a comment.